#REGOMUNE - a phase II #ClinicalTrial of #Regorafenib + #Avelumab in advanced 'cold' #SoftTissueSarcoma—shows that anti-angiogenic therapy modulates the #TumorMicroenvironment and boosts immune-mediated tumor destruction. #medsky
#STTT #OpenAccess: doi.org/10.1038/s413...
0
0
0
0